The bill commissions a data-based study that can clarify cancer risks for fixed‑wing aircrew and guide VA policy and prevention, but benefits will take time, may be limited by data quality, and require VA resources that could delay immediate relief.
Veterans who served as fixed-wing aircrew will get clearer evidence on whether certain cancers are more prevalent or deadly among them, improving awareness and enabling more targeted screening and care.
Provides the VA and Congress with evidence to inform policy decisions, benefits determinations, and presumptive condition designations for affected veterans.
Identifies occupational exposures tied to aircrew service that can inform prevention, monitoring, and workplace-safety measures for current and former aircrew.
Veterans seeking compensation or policy changes may face delays because the study will take time and will not immediately change benefits or care.
Conducting and managing the study requires VA staff time and administrative resources to negotiate, oversee, and share data, potentially diverting resources from clinical services.
Study findings may be limited by the quality and completeness of available administrative data, producing uncertain prevalence estimates for some cancers or exposures.
Based on analysis of 2 sections of legislative text.
Requires the Department of Veterans Affairs to arrange for the National Academies of Sciences, Engineering, and Medicine to study cancer prevalence and mortality among people who served as fixed‑wing military aircrew. The VA must begin negotiations quickly, finalize the agreement on a set timeline or report delays to congressional Veterans’ Affairs committees, and receive a final National Academies report that identifies occupational exposures, reviews links between those exposures and specific cancers, and—where possible—estimates cancer prevalence and mortality using VA, DoD, and public data sources.
Introduced January 23, 2025 by Mark Edward Kelly · Last progress August 14, 2025